In vitro antileishmanial activity of trans-Stilbene (cas 103-30-0) and terphenyl compounds

Add time:08/17/2019    Source:sciencedirect.com

Leishmaniasis are globally widespread parasitic diseases which often leads to death if left untreated. Currently available drugs present different drawbacks, so there is an urgent need to develop new, safe and cost-effective drugs against leishmaniasis. In this study we tested a small library of trans-Stilbene (cas 103-30-0) and terphenyl derivatives against promastigote, amastigotes and intramacrophage amastigote forms of Leishmania infantum. Two compounds of the series, the trans-stilbene 3 and the terphenyl 11, presented the best activity and safety profiles. Terphenyl 11 showed a leshmanicidal activity higher than pentostam and the ability to induce apoptosis selectively in Leishmania infantum while saving macrophages and primary epithelial cells. Our data indicate that terphenyl compounds, as well as stilbenes, are endowed with leishmanicidal activity, showing potential for further studies in the context of leishmanial therapy.

We also recommend Trading Suppliers and Manufacturers of trans-Stilbene (cas 103-30-0). Pls Click Website Link as below: cas 103-30-0 suppliers

Prev:Scintillation properties of solution-grown trans-Stilbene (cas 103-30-0) single crystals
Next:Photochemistry of (trans-4-Styrylpyridine (cas 103-31-1))methyl(trioxo)rhenium(VII). Photoassisted isomerization of 4-Styrylpyridine (cas 103-31-1))